AKORN, INC. Akorn Holding Company, LLC filed a motion in the US Bankruptcy Court for the sale of its certain assets on October 11, 2023. The debtor seeks the Court?s approval for the sale of certain assets to Long Grove Pharmaceuticals, LLC, for a purchase price of $1.35 million pursuant to the asset purchase agreement, dated October 10, 2023. The debtor?s assets include Inventory like Certificate, License and Rights.
The sale hearing is scheduled for November 15, 2023.
